Cargando…

Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity

Liver cancer morbidity and mortality rates differ among ethnic groups. In the United States, the burden of liver cancer in Asian Americans (AS) is higher compared to Caucasian Americans (CA). Research on liver cancer health disparities has mainly focused on environmental and socioeconomic factors ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Khamis, Zahraa I., Pang, Xiaodong, Cui, Zihan, Sang, Qing-Xiang Amy, Zhang, Jinfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486079/
https://www.ncbi.nlm.nih.gov/pubmed/34597305
http://dx.doi.org/10.1371/journal.pone.0257072
_version_ 1784577666459893760
author Khamis, Zahraa I.
Pang, Xiaodong
Cui, Zihan
Sang, Qing-Xiang Amy
Zhang, Jinfeng
author_facet Khamis, Zahraa I.
Pang, Xiaodong
Cui, Zihan
Sang, Qing-Xiang Amy
Zhang, Jinfeng
author_sort Khamis, Zahraa I.
collection PubMed
description Liver cancer morbidity and mortality rates differ among ethnic groups. In the United States, the burden of liver cancer in Asian Americans (AS) is higher compared to Caucasian Americans (CA). Research on liver cancer health disparities has mainly focused on environmental and socioeconomic factors yet has ignored the genotypic differences among various racial/ethnic groups. This lack of molecular level understanding has hindered the development of personalized medical approaches for liver cancer treatment. To understand the genetic heterogeneity of liver cancer between AS and CA, we performed a systematic analysis of RNA-seq data of AS and CA patients from The Cancer Genome Atlas (TCGA). We used four differential gene expression analysis packages; DESeq2, limma, edgeR, and Superdelta2, to identify the differentially expressed genes. Our analysis identified cytochrome P450-2D6 enzyme (CYP2D6) as the gene with the greatest differential expression with higher levels in AS compared to CA. To scrutinize the underlying mechanism of CYP2D6, Ingenuity Pathway Analysis (IPA) and Cytoscape were conducted and found hepatocyte nuclear factor-4α (HNF4A) and interleukin-6 (IL6) in direct association with CYP2D6. IL6 is downregulated in AS compared to CA, while HNF4A is not significantly different. Herein, we report that CYP2D6 may serve as a putative biomarker in liver cancer health disparities. Its negative association with IL6 proclaims an intricate relationship between CYP2D6 and inflammation in the ethnic differences seen in AS and CA liver cancer patients. The goal of the present study was to understand how genetic factors may contribute to the interethnic variability of liver cancer prevalence and outcomes in AS and CA patients. Identifying ethnic-specific genes may help ameliorate detection, diagnosis, surveillance, and treatments of liver cancer, as well as reduce disease-related incidence and mortality rates in the vulnerable population.
format Online
Article
Text
id pubmed-8486079
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-84860792021-10-02 Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity Khamis, Zahraa I. Pang, Xiaodong Cui, Zihan Sang, Qing-Xiang Amy Zhang, Jinfeng PLoS One Research Article Liver cancer morbidity and mortality rates differ among ethnic groups. In the United States, the burden of liver cancer in Asian Americans (AS) is higher compared to Caucasian Americans (CA). Research on liver cancer health disparities has mainly focused on environmental and socioeconomic factors yet has ignored the genotypic differences among various racial/ethnic groups. This lack of molecular level understanding has hindered the development of personalized medical approaches for liver cancer treatment. To understand the genetic heterogeneity of liver cancer between AS and CA, we performed a systematic analysis of RNA-seq data of AS and CA patients from The Cancer Genome Atlas (TCGA). We used four differential gene expression analysis packages; DESeq2, limma, edgeR, and Superdelta2, to identify the differentially expressed genes. Our analysis identified cytochrome P450-2D6 enzyme (CYP2D6) as the gene with the greatest differential expression with higher levels in AS compared to CA. To scrutinize the underlying mechanism of CYP2D6, Ingenuity Pathway Analysis (IPA) and Cytoscape were conducted and found hepatocyte nuclear factor-4α (HNF4A) and interleukin-6 (IL6) in direct association with CYP2D6. IL6 is downregulated in AS compared to CA, while HNF4A is not significantly different. Herein, we report that CYP2D6 may serve as a putative biomarker in liver cancer health disparities. Its negative association with IL6 proclaims an intricate relationship between CYP2D6 and inflammation in the ethnic differences seen in AS and CA liver cancer patients. The goal of the present study was to understand how genetic factors may contribute to the interethnic variability of liver cancer prevalence and outcomes in AS and CA patients. Identifying ethnic-specific genes may help ameliorate detection, diagnosis, surveillance, and treatments of liver cancer, as well as reduce disease-related incidence and mortality rates in the vulnerable population. Public Library of Science 2021-10-01 /pmc/articles/PMC8486079/ /pubmed/34597305 http://dx.doi.org/10.1371/journal.pone.0257072 Text en © 2021 Khamis et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Khamis, Zahraa I.
Pang, Xiaodong
Cui, Zihan
Sang, Qing-Xiang Amy
Zhang, Jinfeng
Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
title Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
title_full Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
title_fullStr Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
title_full_unstemmed Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
title_short Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity
title_sort cytochrome p450-2d6: a novel biomarker in liver cancer health disparity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486079/
https://www.ncbi.nlm.nih.gov/pubmed/34597305
http://dx.doi.org/10.1371/journal.pone.0257072
work_keys_str_mv AT khamiszahraai cytochromep4502d6anovelbiomarkerinlivercancerhealthdisparity
AT pangxiaodong cytochromep4502d6anovelbiomarkerinlivercancerhealthdisparity
AT cuizihan cytochromep4502d6anovelbiomarkerinlivercancerhealthdisparity
AT sangqingxiangamy cytochromep4502d6anovelbiomarkerinlivercancerhealthdisparity
AT zhangjinfeng cytochromep4502d6anovelbiomarkerinlivercancerhealthdisparity